OVASCIENCE, INC. SCHEDULE 13G STATEMENT

Company

Tempest Therapeutics, Inc.

Filed

February 12, 2013

Accession Number

0000897423-13-000014

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →